Skip to Content

667 Results Found

  • Article
  • Open Access
39 Citations
7,032 Views
27 Pages

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections

  • Elizabeth M. Anderson,
  • Francesco R. Simonetti,
  • Robert J. Gorelick,
  • Shawn Hill and ,
  • Monica A. Gouzoulis,
  • Jennifer Bell,
  • Catherine Rehm,
  • Liliana Pérez,
  • Eli Boritz and
  • Frank Maldarelli
  • + 11 authors+ 6 authors

25 January 2020

Combination antiretroviral therapy (cART) controls but does not eradicate HIV infection; HIV persistence is the principal obstacle to curing infections. The proportion of defective proviruses increases during cART, but the dynamics of this process ar...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
34 Citations
7,937 Views
23 Pages

Epigenetic Mechanisms of HIV-1 Persistence

  • Roxane Verdikt,
  • Olivier Hernalsteens and
  • Carine Van Lint

Eradicating HIV-1 in infected individuals will not be possible without addressing the persistence of the virus in its multiple reservoirs. In this context, the molecular characterization of HIV-1 persistence is key for the development of rationalized...

(This article belongs to the Special Issue HIV Pathogenesis, Vaccine and Eradication Strategies)
  • Review
  • Open Access
20 Citations
6,392 Views
15 Pages

HIV-1 Persistence in Children during Suppressive ART

  • Mary Grace Katusiime,
  • Gert U. Van Zyl,
  • Mark F. Cotton and
  • Mary F. Kearney

12 June 2021

There is a growing number of perinatally HIV-1-infected children worldwide who must maintain life-long ART. In early life, HIV-1 infection is established in an immunologically inexperienced environment in which maternal ART and immune dynamics during...

(This article belongs to the Special Issue Mechanisms of Viral Persistence)
  • Review
  • Open Access
20 Citations
4,958 Views
10 Pages

2 September 2021

Antiretroviral therapy (ART) suppresses HIV-1 replication but does not eradicate the virus. Persistence of HIV-1 latent reservoirs in ART-treated individuals is considered the main obstacle to achieving an HIV-1 cure. However, these HIV-1 reservoirs...

(This article belongs to the Special Issue Retroviral RNA Processing)
  • Review
  • Open Access
29 Citations
7,470 Views
19 Pages

17 September 2021

More than 50% of the HIV-1 latent reservoir is maintained by clonal expansion. The clonally expanded HIV-1-infected cells can contribute to persistent nonsuppressible low-level viremia and viral rebound. HIV-1 integration site and proviral genome lan...

(This article belongs to the Special Issue HIV Infection and Spread between T Cells)
  • Review
  • Open Access
27 Citations
5,911 Views
17 Pages

30 June 2020

A hallmark of HIV-1 infection is chronic inflammation, which plays a significant role in disease pathogenesis. Acute HIV infection induces robust inflammatory responses, which are insufficient to prevent or eliminate virus in mucosal tissues. While e...

(This article belongs to the Special Issue Role of Myeloid Cells in Viral Infections)
  • Review
  • Open Access
2 Citations
2,333 Views
41 Pages

Molecular Regulation of HIV-1 Expression and Persistence Across Diverse Cellular Reservoirs

  • Ashlin N. Álvarez-Flores,
  • Fabiola I. Colón-Santiago,
  • Naiara I. Hernández-Santisteban,
  • Julieness M. Correa-Haifa and ,
  • Samuel E. Caldero-Reyes,
  • Glamaris N. Rosario-Sanfiorenzo,
  • Giovanni O. Alicea-Pérez,
  • Gabriela V. Arvelo-Colón,
  • Amanda C. Rivera-Payán and
  • Eduardo Álvarez-Rivera
  • + 12 authors+ 7 authors

Despite the remarkable success of antiretroviral therapy (ART) in suppressing human immunodeficiency virus type 1 (HIV-1) replication, viral persistence remains a major barrier to cure. This persistence is sustained by heterogeneous cellular reservoi...

(This article belongs to the Special Issue HIV Expression in Diverse Cell Types: Mechanisms, Regulation, and Pathogenesis)
  • Review
  • Open Access
1,149 Views
23 Pages

9 July 2026

Ebola virus disease (EVD) has traditionally been considered an acute infection characterized by high mortality and severe systemic inflammation. However, growing evidence accumulated over the last decade has progressively challenged this view, demons...

(This article belongs to the Special Issue The 2026 Central Africa (Bundibugyo) Ebola Virus Outbreak—and Lessons Learned from Previous Ebola Virus Episodes)
  • Review
  • Open Access
814 Views
23 Pages

5 August 2026

Persistent HIV-1 reservoirs remain a major barrier to a durable functional cure despite long-term suppressive antiretroviral therapy. Although resting memory CD4+ T cells constitute the best-characterized cellular reservoir, tissue microenvironments...

(This article belongs to the Special Issue HIV Reservoir Establishment in Myeloid Cells, Restriction Mechanisms and Therapeutic Strategies)
  • Article
  • Open Access
3 Citations
2,000 Views
16 Pages

Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon

  • Mathurin Cyrille Tejiokem,
  • Emilie Desselas,
  • Thierry Joel Noumsi,
  • Francis Ateba Ndongo and ,
  • Suzie Tetang Ndiang,
  • Mireille Arlette Fossi,
  • Georgette Guemkam,
  • Berenice Zangue Kenfack Tekougang,
  • Paul Alain Tagnouokam-Ngoupo and
  • Josiane Warszawski
  • + 7 authors+ 2 authors

Background/Objective: Variations in measles vaccine antibody response by age and HIV status have been reported. This study assessed measles pre-vaccination status and compared humoral response durability over the first five years of life among HIV-in...

  • Review
  • Open Access
21 Citations
4,366 Views
14 Pages

Chronic HIV Transcription, Translation, and Persistent Inflammation

  • Jonathan M. Kilroy,
  • Andrew A. Leal and
  • Andrew J. Henderson

9 May 2024

People with HIV exhibit persistent inflammation that correlates with HIV-associated comorbidities including accelerated aging, increased risk of cardiovascular disease, and neuroinflammation. Mechanisms that perpetuate chronic inflammation in people...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
56 Citations
27,605 Views
27 Pages

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

  • Tessa C. Chou,
  • Nishad S. Maggirwar and
  • Matthew D. Marsden

19 July 2024

The latent reservoir remains a major roadblock to curing human immunodeficiency virus (HIV) infection. Currently available antiretroviral therapy (ART) can suppress active HIV replication, reduce viral loads to undetectable levels, and halt disease p...

(This article belongs to the Special Issue HIV Reservoirs, Latency, and the Factors Responsible)
  • Review
  • Open Access
14 Citations
5,456 Views
25 Pages

HIV-1 Natural Antisense Transcription and Its Role in Viral Persistence

  • Rui Li,
  • Rachel Sklutuis,
  • Jennifer L. Groebner and
  • Fabio Romerio

29 April 2021

Natural antisense transcripts (NATs) represent a class of RNA molecules that are transcribed from the opposite strand of a protein-coding gene, and that have the ability to regulate the expression of their cognate protein-coding gene via multiple mec...

(This article belongs to the Special Issue Mechanisms of Viral Persistence)
  • Review
  • Open Access
26 Citations
8,456 Views
24 Pages

Humanized Mice for Studies of HIV-1 Persistence and Elimination

  • Chen Zhang,
  • Lubaba A. Zaman,
  • Larisa Y. Poluektova,
  • Santhi Gorantla and ,
  • Howard E. Gendelman and
  • Prasanta K. Dash
  • + 1 author+ 0 author

A major roadblock to achieving a cure for human immunodeficiency virus type one (HIV-1) is the persistence of latent viral infections in the cells and tissue compartments of an infected human host. Latent HIV-1 proviral DNA persists in resting memory...

(This article belongs to the Section Immunological Responses and Immune Defense Mechanisms)
  • Review
  • Open Access
17 Citations
5,792 Views
12 Pages

Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence

  • Laurens Lambrechts,
  • Basiel Cole,
  • Sofie Rutsaert,
  • Wim Trypsteen and
  • Linos Vandekerckhove

28 January 2020

While current antiretroviral therapies are able to halt HIV-1 progression, they are not curative, as an interruption of treatment usually leads to viral rebound. The persistence of this stable HIV-1 latent reservoir forms the major barrier in HIV-1 c...

(This article belongs to the Special Issue HIV-1 Latency: Regulation and Reversal)
  • Article
  • Open Access
3 Citations
3,249 Views
11 Pages

Association of SARS-CoV-2 Seropositivity with Persistent Immune Activation in HIV/Tuberculosis Co-Infected Patients

  • Ashwini Shete,
  • Manisha Ghate,
  • Hiroko Iwasaki-Hozumi,
  • Sandip Patil and ,
  • Pallavi Shidhaye,
  • Takashi Matsuba,
  • Gaowa Bai,
  • Pratiksha Pharande and
  • Toshio Hattori
  • + 4 authors+ 0 author

29 July 2024

We asked if SARS-CoV-2 seropositivity in HIV/TB co-infected patients plays a role in precipitating active tuberculosis in HIV-infected individuals and alters inflammatory status. A prospective study was conducted on HIV/TB co-infected patients presen...

  • Article
  • Open Access
8 Citations
3,900 Views
13 Pages

Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa

  • Nokukhanya Msomi,
  • Raveen Parboosing,
  • Eduan Wilkinson,
  • Jennifer Giandhari and ,
  • Kerusha Govender,
  • Benjamin Chimukangara and
  • Koleka P. Mlisana
  • + 2 authors+ 0 author

10 April 2022

To understand the problem of persistent Hepatitis B virus (HBV) viraemia in HIV/HBV co-infected patients on HBV-active antiretroviral therapy (ART), we assessed the rate of HBV virological response in patients on HBV-active ART in KwaZulu-Natal, Sout...

(This article belongs to the Special Issue State-of-the-Art Virology Research in South Africa)
  • Article
  • Open Access
13 Citations
5,378 Views
12 Pages

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells

  • Laura E. P. Huyveneers,
  • Anke Bruns,
  • Arjen Stam,
  • Pauline Ellerbroek and ,
  • Dorien de Jong,
  • Noémi A. Nagy,
  • Stephanie B. H. Gumbs,
  • Kiki Tesselaar,
  • Kobus Bosman and
  • Monique Nijhuis
  • + 18 authors+ 13 authors

17 September 2022

Allo-HSCT with CCR5Δ32/Δ32 donor cells is the only curative HIV-1 intervention. We investigated the impact of allo-HSCT on the viral reservoir in PBMCs and post-mortem tissue in two patients. IciS-05 and IciS-11 both received a CCR5&Delta...

(This article belongs to the Special Issue HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 2.0)
  • Review
  • Open Access
1,229 Views
26 Pages

The human gut microbiome is essential for immune regulation and mucosal homeostasis, functions that are profoundly disrupted during HIV infection. Early viral replication in the gut-associated lymphoid tissue (GALT) triggers a self-reinforcing cycle...

(This article belongs to the Special Issue Host–Microorganism Interaction)
  • Review
  • Open Access
16 Citations
5,186 Views
21 Pages

27 April 2020

In adherent individuals, antiretroviral therapy (ART) suppresses HIV replication, restores immune function, and prevents the development of AIDS. However, ART is not curative and has to be followed lifelong. Persistence of viral reservoirs forms the...

(This article belongs to the Special Issue Antiretroviral Drug Development and HIV Cure Research)
  • Review
  • Open Access
16 Citations
6,268 Views
26 Pages

Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”

  • Chiara Acchioni,
  • Enrico Palermo,
  • Silvia Sandini,
  • Marta Acchioni and ,
  • John Hiscott and
  • Marco Sgarbanti
  • + 1 author+ 0 author

20 November 2021

Despite the success of highly active antiretroviral therapy (HAART), integrated HIV-1 proviral DNA cannot be eradicated from an infected individual. HAART is not able to eliminate latently infected cells that remain invisible to the immune system. Vi...

(This article belongs to the Special Issue Pathogenesis, Molecular Epidemiology, and Immune Response to Lentiviral Infections)
  • Review
  • Open Access
13 Citations
4,652 Views
15 Pages

21 February 2021

Antiretroviral therapy (ART) has dramatically suppressed human immunodeficiency virus (HIV) replication and become undetectable viremia. However, a small number of residual replication-competent HIV proviruses can still persist in a latent state even...

(This article belongs to the Special Issue Mechanisms of Viral Persistence)
  • Review
  • Open Access
22 Citations
4,246 Views
18 Pages

22 January 2025

Human immunodeficiency virus (HIV) infection induces chronic immune activation by stimulating both the innate and adaptive immune systems, resulting in persistent inflammation and immune cell exhaustion. Of note, the modulation of cytokine production...

(This article belongs to the Special Issue Innate Immunity to Virus Infection 2nd Edition)
  • Review
  • Open Access
8 Citations
7,093 Views
27 Pages

HIV Expression in Infected T Cell Clones

  • Jason W. Rausch,
  • Shadab Parvez,
  • Sachi Pathak,
  • Adam A. Capoferri and
  • Mary F. Kearney

11 January 2024

The principal barrier to an HIV-1 cure is the persistence of infected cells harboring replication-competent proviruses despite antiretroviral therapy (ART). HIV-1 transcriptional suppression, referred to as viral latency, is foremost among persistenc...

(This article belongs to the Special Issue Regulation of HIV-1 Transcription and Latency)
  • Review
  • Open Access
6 Citations
4,039 Views
20 Pages

HIV-1 Tat acts as a central molecular switch governing the transition between viral latency and active replication, making it a pivotal target for HIV-1 functional cure strategies. By binding to the viral long terminal repeat (LTR) and hijacking host...

(This article belongs to the Section Molecular Microbiology)
  • Review
  • Open Access
43 Citations
14,718 Views
30 Pages

3 March 2016

The plasma membrane protects the cell from its surroundings and regulates cellular communication, homing, and metabolism. Not surprisingly, the composition of this membrane is highly controlled through the vesicular trafficking of proteins to and fro...

(This article belongs to the Special Issue Host Membranes and the Viral Infection Cycle)
  • Article
  • Open Access
10 Citations
3,126 Views
17 Pages

Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV

  • Valérie Desquiret-Dumas,
  • Morgana D’Ottavi,
  • Audrey Monnin,
  • David Goudenège and ,
  • Nicolas Méda,
  • Amélie Vizeneux,
  • Chipepo Kankasa,
  • Thorkild Tylleskar,
  • Céline Bris and
  • Jean-Pierre Molès
  • + 9 authors+ 4 authors

HIV-exposed uninfected (HEU) children show impaired health outcomes during childhood. A high rate of mitochondrial DNA (mtDNA) instability was reported in the blood of HEU at birth. We aimed to explore the relationship between these health outcomes a...

(This article belongs to the Section Cell Biology and Pathology)
  • Commentary
  • Open Access
11 Citations
4,263 Views
16 Pages

19 September 2021

HIV persists via integration of the viral DNA into the human genome. The HIV DNA pool within an infected individual is a complex population that comprises both intact and defective viral genomes, each with a distinct integration site, in addition to...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
19 Citations
5,619 Views
24 Pages

15 October 2021

HIV infection is not curable with current antiretroviral therapy (ART) because a small fraction of CD4+ T cells infected prior to ART initiation persists. Understanding the nature of this latent reservoir and how it is created is essential to develop...

(This article belongs to the Special Issue Mechanisms of Viral Persistence)
  • Review
  • Open Access
113 Views
38 Pages

10 November 2026

Despite sustained suppression of viral replication by antiretroviral therapy (ART), HIV-1 persists in long-lived and clonally expanding infected-cell populations across anatomical compartments. This persistence reflects interactions among proviral re...

(This article belongs to the Special Issue Immunity in Persistent Viral Infection and AI Guided Antiviral Drug Design)
  • Review
  • Open Access
43 Views
32 Pages

Human Pegivirus (HPgV) as an Immunomodulator in HIV Infection: Markers of Disease Progression and Therapeutic Perspectives

  • Arina A. Kiryakina,
  • Margarita A. Boyko,
  • Kirill A. Elfimov,
  • Andrei I. Murzin and ,
  • Alexandr P. Agaphonov and
  • Natalya M. Gashnikova
  • + 1 author+ 0 author

15 November 2026

Human pegivirus 1 (HPgV-1) is a widespread RNA virus detected in lymphoid and other hematopoietic cells, although its principal cellular reservoir in vivo remains uncertain. In people living with HIV-1 (PLWH), persistent HPgV-1 viremia has been assoc...

(This article belongs to the Special Issue Cross-Pathogen Insights into Infectious Diseases: From Biomarkers to Burden and Therapeutic Strategies of Viral Pathogens)
  • Review
  • Open Access
4 Citations
3,342 Views
28 Pages

HIV-Induced Apoptosis: Host Defense and Viral Strategy

  • David Chisompola,
  • Phinnoty Mwansa,
  • John Nzobokela,
  • Magdalene Ameka and ,
  • Annet Kirabo,
  • Antentor Hinton and
  • Sepiso K. Masenga
  • + 2 authors+ 0 author

26 November 2025

HIV-induced apoptosis is a contradictory complicated phenomenon that occurs at the intersection of viral persistence and host defense. HIV primarily affects CD4 T cells during an infection, causing widespread immune cell death through both direct inf...

(This article belongs to the Special Issue Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism (2nd Edition))
  • Article
  • Open Access
3 Citations
2,969 Views
12 Pages

Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy

  • Valentina Perrone,
  • Melania Dovizio,
  • Diego Sangiorgi,
  • Margherita Andretta and ,
  • Fausto Bartolini,
  • Arturo Cavaliere,
  • Andrea Ciaccia,
  • Alessandro Chinellato,
  • Alberto Costantini and
  • Luca Degli Esposti
  • + 16 authors+ 11 authors

This real-world analysis conducted on administrative databases of a sample of Italian healthcare entities was aimed at describing the role of therapeutic pathways and drug utilization in terms of adherence, persistence, and therapy discontinuation in...

(This article belongs to the Section Infectious Disease Epidemiology)
  • Review
  • Open Access
31 Citations
10,428 Views
30 Pages

Macrophages: Key Cellular Players in HIV Infection and Pathogenesis

  • Marie Woottum,
  • Sen Yan,
  • Sophie Sayettat,
  • Séverine Grinberg and ,
  • Dominique Cathelin,
  • Nassima Bekaddour,
  • Jean-Philippe Herbeuval and
  • Serge Benichou
  • + 3 authors+ 0 author

13 February 2024

Although cells of the myeloid lineages, including tissue macrophages and conventional dendritic cells, were rapidly recognized, in addition to CD4+ T lymphocytes, as target cells of HIV-1, their specific roles in the pathophysiology of infection were...

(This article belongs to the Special Issue Roles of Macrophages in Viral Infections)
  • Review
  • Open Access
38 Citations
8,522 Views
43 Pages

14 December 2021

Antiretroviral therapy (ART) effectively reduces cycles of viral replication but does not target proviral populations in cells that persist for prolonged periods and that can undergo clonal expansion. Consequently, chronic human immunodeficiency viru...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
1 Citations
843 Views
14 Pages

Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania

  • Faithness Kiondo,
  • Emmy Metta,
  • Elia John Mmbaga,
  • Kåre Moen and ,
  • Calvin Swai and
  • Melkzedeck Leshabari
  • + 1 author+ 0 author

21 January 2026

Background: Pre-exposure prophylaxis (PrEP) offers over 99% protection against HIV when used consistently, but stigma continues to undermine persistence in care. While much research has described the external manifestations of PrEP-related stigma, le...

  • Article
  • Open Access
5 Citations
3,229 Views
12 Pages

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1

  • Grant Klug,
  • Frances M. Cole,
  • Mark D. Hicar,
  • Connie Watt and ,
  • Tami Peters and
  • Seth H. Pincus
  • + 1 author+ 0 author

12 April 2023

We are developing cytotoxic immunoconjugates (CICs) targeting the envelope protein (Env) of the Human Immunodeficiency Virus, type 1 (HIV) to purge the persistent reservoirs of viral infection. We have previously studied the ability of multiple monoc...

  • Communication
  • Open Access
181 Views
14 Pages

Distinct HIV-1 Proviral Integration Region Landscapes Across Acute Naïve, Chronic Naïve, and Successfully Treated Patient Cohorts

  • Giuseppe Sberna,
  • Giulia Berno,
  • Cesare Ernesto Maria Gruber,
  • Gabriella Rozera and ,
  • Elisabetta Lazzari,
  • Lavinia Fabeni,
  • Federica Forbici,
  • Valentina Mazzotta,
  • Roberta Gagliardini and
  • Isabella Abbate
  • + 10 authors+ 5 authors

28 October 2026

HIV-1 proviral integration into the human genome dictates viral and host gene expression, as well as HIV reservoir persistence. This study analyzed insertion site (IS) landscapes in three groups of people with HIV (PWH): acute (AHI) naïve (n = 8...

(This article belongs to the Special Issue HIV Reservoirs, Latency, and the Factors Responsible (2nd Edition))
  • Review
  • Open Access
44 Citations
10,036 Views
41 Pages

HIV-1 Proviral Transcription and Latency in the New Era

  • Ashutosh Shukla,
  • Nora-Guadalupe P. Ramirez and
  • Iván D’Orso

18 May 2020

Three decades of extensive work in the HIV field have revealed key viral and host cell factors controlling proviral transcription. Various models of transcriptional regulation have emerged based on the collective information from in vitro assays and...

(This article belongs to the Special Issue HIV-1 Transcription Regulation)
  • Article
  • Open Access
995 Views
23 Pages

SHIV.D Infection Alters Production and Protein Composition of Myeloid-Derived Extracellular Vesicles

  • Rachel M. Podgorski,
  • Amir Yarmahmoodi,
  • Stephen Baak,
  • Rebecca Warfield and ,
  • Jake A. Robinson,
  • Jennifer Roof,
  • Maurizio Caocci,
  • Hossein Fazelinia,
  • Lynn A. Spruce and
  • Tricia H. Burdo
  • + 6 authors+ 1 author

Although neurological disease is common in people with human immunodeficiency virus (HIV) (PWH), the contributing factors and underlying inflammatory mechanisms remain challenging to identify. Extracellular vesicles (EVs) constitute a relatively unch...

(This article belongs to the Section Molecular Nanoscience)
  • Article
  • Open Access
1,085 Views
17 Pages

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy

  • Luca Degli Esposti,
  • Stefania Mazzoni,
  • Maria Cappuccilli,
  • Franco Maggiolo and ,
  • Sergio Lo Caputo,
  • Silvia Nozza,
  • Lucia Taramasso,
  • Anna Marra and
  • Mario Pittorru
  • + 4 authors+ 0 author

18 March 2026

Background/Objectives: Among the antiretroviral therapies (ARTs) recently introduced for people living with HIV (PLWH), the fixed-dose combination of bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF) became reimbursable in Italy in June...

  • Feature Paper
  • Review
  • Open Access
2 Citations
4,011 Views
16 Pages

15 February 2023

The cure for chronic human immunodeficiency virus (HIV) infections has been a goal pursued since the antiretroviral therapy that improved the clinical conditions of patients became available. However, the exclusive use of these drugs is not enough to...

(This article belongs to the Section Immunological Responses and Immune Defense Mechanisms)
  • Article
  • Open Access
12 Citations
2,021 Views
23 Pages

Periodic Behaviour of HIV Dynamics with Three Infection Routes

  • Miled El Hajji and
  • Rahmah Mohammed Alnjrani

29 December 2023

In this study, we consider a system of nonlinear differential equations modeling the human immunodeficiency virus type-1 (HIV-1) in a variable environment. Infected cells were subdivided into two compartments describing both latently and productively...

(This article belongs to the Special Issue Mathematical Modeling and Analysis in Biology and Medicine, 2nd Edition)
  • Article
  • Open Access
13 Citations
4,057 Views
10 Pages

Clinical Course of Opportunistic Infections—Toxoplasmosis and Cytomegalovirus Infection in HIV-Infected Patients in Slovakia

  • Katarína Šimeková,
  • Elena Nováková,
  • Róbert Rosoľanka,
  • Jana Masná and
  • Daniela Antolová

4 November 2019

The HIV/acquired immunodeficiency syndrome (AIDS) pandemic has affected the health status of the population in many countries. Early symptomatic HIV infection includes persistent generalized lymphadenopathy (PGL), which can be associated with opportu...

(This article belongs to the Section Human Pathogens)
  • Article
  • Open Access
5 Citations
3,243 Views
27 Pages

25 December 2022

Taking into account the effects of the heterogeneity of the population and media coverage on disease transmission, in this paper, a hybrid HIV/AIDS model with age-structure, self-protection awareness and media coverage is formulated, which is made up...

(This article belongs to the Section E3: Mathematical Biology)
  • Article
  • Open Access
17 Citations
3,304 Views
12 Pages

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series

  • Bianca Maria Longo,
  • Francesco Venuti,
  • Alberto Gaviraghi,
  • Tommaso Lupia and ,
  • Fabio Antonino Ranzani,
  • Andrea Pepe,
  • Laura Ponzetta,
  • Davide Vita,
  • Tiziano Allice and
  • Stefano Bonora
  • + 9 authors+ 4 authors

19 September 2023

Prolonged SARS-CoV-2 infections are widely described in immunosuppressed patients, but safe and effective treatment strategies are lacking. We aimed to outline our approach to treating persistent COVID-19 in patients with immunosuppression from diffe...

(This article belongs to the Special Issue Healthcare-Associated Infections (HAIs): Prevention, Control and Surveillance)
  • Review
  • Open Access
48 Citations
8,911 Views
16 Pages

7 July 2015

Drug resistance prevents the successful treatment of HIV-positive individuals by decreasing viral sensitivity to a drug or a class of drugs. In addition to transmitted resistant viruses, treatment-naïve individuals can be confronted with the problem...

(This article belongs to the Special Issue Gene Technology and Resistance to Viruses - Reviews)
  • Article
  • Open Access
13 Citations
4,728 Views
14 Pages

Impaired Hematologic Status in Relation to Clinical Outcomes among HIV-Infected Adults from Uganda: A Prospective Cohort Study

  • Amara E. Ezeamama,
  • David Guwatudde,
  • Alla Sikorskii,
  • Edmond K. Kabagambe and ,
  • Raybun Spelts,
  • Grace Vahey,
  • Jenifer I. Fenton and
  • Wafaie W. Fawzi
  • + 3 authors+ 0 author

12 April 2018

Impaired hematologic status (IHS) was investigated as a determinant of immune function defined as cluster of differentiation 4 (CD4) T-helper cell count, quality of life (QOL) weight and hospitalization/mortality over 18-months among 398 adult person...

  • Article
  • Open Access
17 Citations
4,101 Views
13 Pages

IgG Antibody Responses and Immune Persistence of Two Doses of BBIBP-CorV Vaccine or CoronaVac Vaccine in People Living with HIV (PLWH) in Shenzhen, China

  • Guang Zeng,
  • Liumei Xu,
  • Shuidong Feng,
  • Jie Tang and ,
  • Xiaohui Wang,
  • Guilian Li,
  • Yongxia Gan,
  • Chenli Zheng,
  • Jin Zhao and
  • Zhengrong Yang
  • + 5 authors+ 0 author

The purpose of this study was to preliminarily evaluate the immunogenicity and immune persistence of inactivated SARS-CoV-2 vaccines in PLWH in the real world. We collected blood samples from 132 PLWH aged 18–59 years who were vaccinated with t...

(This article belongs to the Special Issue Immune Responses to COVID-19 Vaccines)

of 14